로딩 중…
StockDiggingStockDigging

Thermo Fisher Scientific Inc.

TMO· NYSE
$464.75+0.66%
2026-06-18

Price Chart

Thermo Fisher Scientific Inc.+18.58%

Financials

※ FY = Fiscal Year

Investment Metrics(as of 2026-06-18)

MetricValue
Size
Market Cap$172.71B
Revenue$45.20B
Net Income$6.86B
Total Assets$113.28B
Net Assets$51.94B
Employees125,000
Value
P/E25.18x
P/B3.33x
PEG2.64x
P/S3.82x
EV/EBITDA19.05x
FCF Yield3.91%
Profitability
ROE13.21%
ROA6.05%
Op. Margin17.76%
Revenue Growth6.18%
Earnings Growth9.56%
Financial Health
Debt Ratio118.10%
Total Debt$43.16B
FCF$6.75B
Cash$3.25B
Current Ratio1.53x
Net Debt/EBITDA3.58x
Dividend
Div. Yield0.38%
Div. Growth10.83%
Performance
1Y Return18.58%
1M Return3.78%
From 52W High-27.83%
1Y MDD-31.45%
Trading
Volume1,601,765 shares
Trading Value$743M
Per Share
EPS$17.86
BPS$142.04

Company Info

CEO Mr. Marc N. Casper
Employees 125,000
HQ Waltham, United States

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.